Plasma and Hepatic Cholesterol and Hepatic Activities of 3-Hydroxy-3-methyl-glutaryl-CoA Reductase and Acyl CoA: Cholesterol Transferase Are Lower in Rats Fed Citrus Peel Extract or a Mixture of Citrus Bioflavonoids
Open Access
- 1 June 1999
- journal article
- research article
- Published by Elsevier in Journal of Nutrition
- Vol. 129 (6) , 1182-1185
- https://doi.org/10.1093/jn/129.6.1182
Abstract
The cholesterol-lowering effects of tangerine peel extract and a mixture of two citrus flavonoids were tested. Male rats were fed a 1 g/100 g high-cholesterol diet for 42 d with supplements of either tangerine-peel extract or a mixture of naringin and hesperidin (0.5 g/100 g) to study the effects of plasma and hepatic lipids, hepatic enzyme activities, and the excretion of fecal neutral sterols. Both the tangerine-peel extract and mixture of two flavonoids significantly lowered the levels (mean ± SE) of plasma (2.44 ± 0.59 and 2.42 ± 0.31 mmol/L, vs. 3.80 ± 0.28 mmol/L, P < 0.05), hepatic cholesterol (0.143 ± 0.017 and 0.131 ± 0.010 mmol/g vs. 0.181 ± 0.003 mmol/g, P < 0.05), and hepatic triglycerides (0.069 ± 0.007 and 0.075 ± 0.006 mmol/g vs. 0.095 ± 0.002 mmol/g, P < 0.05) compared to those of the control. The 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase (1565.0 ± 106.0 pmol · min−1 · mg protein−1 and 1783.0 ± 282 pmol · min−1 · mg protein−1 vs. 2487.0 ± 210.0 pmol · min−1 · mg protein−1, P < 0.05) and acyl CoA: cholesterol O-acyltransferase (ACAT) activities (548.0 ± 65.0 and 615.0 ± 80.0 pmol · min−1 · mg protein−1 vs. 806.0 ± 105.0 pmol · min−1 · mg protein−1, P < 0.05) were significantly lower in the experimental groups than in the control. These supplements also substantially reduced the excretion of fecal neutral sterols compared to the control (211.1 ± 26.7 and 208.2 ± 31.6 mg/d vs. 521.9 ± 53.9 mg/d). The inhibition of HMG-CoA reductase and ACAT activities resulting from the supplementation of either tangerine-peel extract or a combination of its bioflavonoids could account for the decrease in fecal neutral sterol that appears to compensate for the decreased cholesterol biosynthesis in the liver.Keywords
This publication has 29 references indexed in Scilit:
- Serum cholesterol and ischaemic heart diseaseAtherosclerosis, 1995
- Pharmacological Evaluation of the Anti-inflammatory Activity of a Citrus Bioflavonoid, Hesperidin, and the Isoflavonoids, Duartin and Claussequinone, in Rats and MiceJournal of Pharmacy and Pharmacology, 1994
- RG 12561 (Dalvastatin): A Novel Synthetic Inhibitor of HMG-CoA Reductase and Cholesterol-Lowering AgentPharmacology, 1993
- Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Esterification and absorption of cholesterol: in vitro and in vivo observations in the ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Regulation of acyl-CoA:Cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: Role of a cholesterol substrate poolExperimental and Molecular Pathology, 1986
- Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animalsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- Comparative mutagenesis of plant flavonoids in microbial systemsMutation Research/Genetic Toxicology, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Micro assay for 3-hdyroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblastsBiochimica et Biophysica Acta (BBA) - Enzymology, 1974